Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Uveal Melanoma 4Melanoma 2Sarcoma, Clear Cell 1Sarcoma 1Neoplasm Metastasis 1

Interventions

Ifosfamide 2Doxorubicin 2Cyclophosphamide 2tebentafusp 1selinexor 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pazopanib 1fludarabine phosphate 1fludarabine 1cobimetinib 1Zoledronic Acid 1Vemurafenib 1Topotecan 1Sunitinib 1Sirolimus 1Simvastatin 1Radiotherapy, Image-Guided 1Radiation Dose Hypofractionation 1Proton Therapy 1Nivolumab 1Methotrexate 1Mesna 1Granulocyte Colony-Stimulating Factor 1Epirubicin 1Diathermy 1Dacarbazine 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Clear Cell × tebentafusp × Clear all
NCT06942442 2025-12-26

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

Sarcoma Alliance for Research through Collaboration

Phase 2 Recruiting
47 enrolled
Sarcoma

Sarcoma, Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡